

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 8.50240841 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.41423317 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.27952554 |
| 4 | drug catabolic process (GO:0042737) | 8.07474919 |
| 5 | exogenous drug catabolic process (GO:0042738) | 8.06726565 |
| 6 | regulation of protein activation cascade (GO:2000257) | 7.58525108 |
| 7 | regulation of fibrinolysis (GO:0051917) | 7.55592397 |
| 8 | regulation of complement activation (GO:0030449) | 7.26281345 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.16842309 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.16842309 |
| 11 | glyoxylate metabolic process (GO:0046487) | 6.92580511 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 6.88058326 |
| 13 | regulation of plasminogen activation (GO:0010755) | 6.41966703 |
| 14 | protein carboxylation (GO:0018214) | 6.34338886 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.34338886 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.31658505 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 6.31658505 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 5.84676380 |
| 19 | opsonization (GO:0008228) | 5.82767759 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78764349 |
| 21 | urea metabolic process (GO:0019627) | 5.74987911 |
| 22 | ethanol oxidation (GO:0006069) | 5.64175667 |
| 23 | fibrinolysis (GO:0042730) | 5.61922838 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 5.58574897 |
| 25 | drug metabolic process (GO:0017144) | 5.47612940 |
| 26 | imidazole-containing compound metabolic process (GO:0052803) | 5.36643840 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.32481925 |
| 28 | oxidative demethylation (GO:0070989) | 5.30320727 |
| 29 | acute-phase response (GO:0006953) | 5.23779660 |
| 30 | protein activation cascade (GO:0072376) | 5.20191527 |
| 31 | complement activation (GO:0006956) | 5.18139785 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 5.12343527 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 5.10867642 |
| 34 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.99971554 |
| 35 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.99971554 |
| 36 | urea cycle (GO:0000050) | 4.94525003 |
| 37 | complement activation, classical pathway (GO:0006958) | 4.92068469 |
| 38 | regulation of humoral immune response (GO:0002920) | 4.91109118 |
| 39 | negative regulation of sterol transport (GO:0032372) | 4.87583957 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.87583957 |
| 41 | negative regulation of protein activation cascade (GO:2000258) | 4.73329487 |
| 42 | phenylpropanoid metabolic process (GO:0009698) | 4.71212140 |
| 43 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.68382114 |
| 44 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.68382114 |
| 45 | alkaloid metabolic process (GO:0009820) | 4.68250539 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.50458033 |
| 47 | ethanol metabolic process (GO:0006067) | 4.47917769 |
| 48 | bile acid biosynthetic process (GO:0006699) | 4.47184990 |
| 49 | S-adenosylmethionine metabolic process (GO:0046500) | 4.46843613 |
| 50 | cytolysis (GO:0019835) | 4.44457294 |
| 51 | glutamate metabolic process (GO:0006536) | 4.42323501 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.38488544 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.38488544 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.38488544 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.34984455 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.34984455 |
| 57 | glycine metabolic process (GO:0006544) | 4.27668206 |
| 58 | phospholipid efflux (GO:0033700) | 4.24890729 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 4.22922123 |
| 60 | negative regulation of hemostasis (GO:1900047) | 4.22922123 |
| 61 | bile acid metabolic process (GO:0008206) | 4.18472332 |
| 62 | cellular glucuronidation (GO:0052695) | 4.10906406 |
| 63 | negative regulation of complement activation (GO:0045916) | 3.97213749 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.92816696 |
| 65 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.91138792 |
| 66 | cholesterol efflux (GO:0033344) | 3.86898051 |
| 67 | cysteine metabolic process (GO:0006534) | 3.85693182 |
| 68 | glucuronate metabolic process (GO:0019585) | 3.84053011 |
| 69 | uronic acid metabolic process (GO:0006063) | 3.84053011 |
| 70 | negative regulation of wound healing (GO:0061045) | 3.83905070 |
| 71 | bile acid and bile salt transport (GO:0015721) | 3.83782260 |
| 72 | sulfur amino acid catabolic process (GO:0000098) | 3.83279149 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.79103918 |
| 74 | acute inflammatory response (GO:0002526) | 3.77915068 |
| 75 | negative regulation of coagulation (GO:0050819) | 3.73187973 |
| 76 | regulation of apoptotic cell clearance (GO:2000425) | 3.68659127 |
| 77 | positive regulation of hemostasis (GO:1900048) | 3.66575542 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 3.66575542 |
| 79 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.66204961 |
| 80 | regulation of acute inflammatory response (GO:0002673) | 3.59340916 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.57218772 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 3.55065455 |
| 83 | serine family amino acid biosynthetic process (GO:0009070) | 3.53624458 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.52383631 |
| 85 | arginine metabolic process (GO:0006525) | 3.50463457 |
| 86 | plasma lipoprotein particle organization (GO:0071827) | 3.47307914 |
| 87 | flavonoid metabolic process (GO:0009812) | 3.46935075 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.45974376 |
| 89 | positive regulation of coagulation (GO:0050820) | 3.40387874 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.38893424 |
| 91 | negative regulation of humoral immune response (GO:0002921) | 3.37033682 |
| 92 | heme transport (GO:0015886) | 3.30519026 |
| 93 | cellular ketone body metabolic process (GO:0046950) | 3.27993690 |
| 94 | tryptophan catabolic process (GO:0006569) | 3.27779050 |
| 95 | indole-containing compound catabolic process (GO:0042436) | 3.27779050 |
| 96 | indolalkylamine catabolic process (GO:0046218) | 3.27779050 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.27517923 |
| 98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.25700798 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.24325035 |
| 100 | protein-lipid complex subunit organization (GO:0071825) | 3.22817028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.82644008 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.31377184 |
| 3 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.60498302 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.57672178 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.51845728 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89526371 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85180579 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.78099180 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.77155684 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.33058318 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.84102944 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25625026 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16348233 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.04821148 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.86909025 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69314975 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65955797 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58692711 |
| 19 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54869778 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.47032876 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45488255 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44947042 |
| 23 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44873915 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42071591 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41041927 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40812513 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38375873 |
| 28 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35628427 |
| 29 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34789660 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33444911 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33001665 |
| 32 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32026394 |
| 33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30386972 |
| 34 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29539565 |
| 35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27950569 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24847567 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.23758400 |
| 38 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23704095 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23568439 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20635867 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18344211 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15255105 |
| 43 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15215883 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13785970 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12199139 |
| 46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11860958 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11089511 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10335105 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.09427114 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09233904 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07110427 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06477080 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06024614 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05620263 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04897419 |
| 56 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02602584 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02469695 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01820835 |
| 59 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00301810 |
| 60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00088086 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99768439 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96756413 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96398989 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.96131343 |
| 65 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.95974730 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95212247 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94875787 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93934009 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 0.93608162 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91836785 |
| 71 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.91799446 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91696072 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90982527 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90615992 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88082416 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 0.87973787 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87771176 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87274947 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 0.85520794 |
| 80 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.85499300 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85382576 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85373729 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85098658 |
| 84 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.84380295 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84141000 |
| 86 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.84051031 |
| 87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83633525 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.83453196 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.82555414 |
| 90 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.80580579 |
| 91 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.80561738 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80536732 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80460884 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79870594 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79454980 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79085441 |
| 97 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78697978 |
| 98 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.78099901 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76923763 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76895437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.75122065 |
| 2 | MP0005360_urolithiasis | 6.32480670 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11473988 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.02361444 |
| 5 | MP0003195_calcinosis | 4.90087051 |
| 6 | MP0005365_abnormal_bile_salt | 4.75761949 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.73232703 |
| 8 | MP0003252_abnormal_bile_duct | 3.46483313 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.79165389 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.65399388 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.53658068 |
| 12 | MP0003868_abnormal_feces_composition | 2.24146154 |
| 13 | MP0005332_abnormal_amino_acid | 2.10010843 |
| 14 | MP0005670_abnormal_white_adipose | 2.05339049 |
| 15 | MP0009840_abnormal_foam_cell | 1.85406975 |
| 16 | MP0003436_decreased_susceptibility_to | 1.77922991 |
| 17 | MP0000609_abnormal_liver_physiology | 1.75842850 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.68621895 |
| 19 | MP0001764_abnormal_homeostasis | 1.57542318 |
| 20 | MP0002132_abnormal_respiratory_system | 1.51400951 |
| 21 | MP0002876_abnormal_thyroid_physiology | 1.49080615 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.42570485 |
| 23 | MP0009764_decreased_sensitivity_to | 1.33193799 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.30846331 |
| 25 | MP0009785_altered_susceptibility_to | 1.28257733 |
| 26 | MP0002971_abnormal_brown_adipose | 1.19902940 |
| 27 | MP0003724_increased_susceptibility_to | 1.19795417 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.19180710 |
| 29 | MP0000604_amyloidosis | 1.18065557 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.17424129 |
| 31 | MP0003879_abnormal_hair_cell | 1.14758881 |
| 32 | MP0001661_extended_life_span | 1.11997503 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.09877363 |
| 34 | MP0008469_abnormal_protein_level | 1.08540031 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.05121510 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.01076723 |
| 37 | MP0000598_abnormal_liver_morphology | 0.97639032 |
| 38 | MP0002419_abnormal_innate_immunity | 0.97454778 |
| 39 | MP0009697_abnormal_copulation | 0.96638786 |
| 40 | MP0003303_peritoneal_inflammation | 0.94649292 |
| 41 | MP0009763_increased_sensitivity_to | 0.94202080 |
| 42 | MP0010368_abnormal_lymphatic_system | 0.94124726 |
| 43 | MP0002249_abnormal_larynx_morphology | 0.93933951 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91336185 |
| 45 | MP0009642_abnormal_blood_homeostasis | 0.90158630 |
| 46 | MP0005025_abnormal_response_to | 0.87243410 |
| 47 | MP0005451_abnormal_body_composition | 0.86445645 |
| 48 | MP0003690_abnormal_glial_cell | 0.84804251 |
| 49 | MP0005535_abnormal_body_temperature | 0.83922126 |
| 50 | MP0009643_abnormal_urine_homeostasis | 0.83726512 |
| 51 | MP0005058_abnormal_lysosome_morphology | 0.82311494 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.81280665 |
| 53 | MP0001800_abnormal_humoral_immune | 0.80781797 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 0.79186444 |
| 55 | MP0008874_decreased_physiological_sensi | 0.78873863 |
| 56 | MP0004130_abnormal_muscle_cell | 0.78376704 |
| 57 | MP0002282_abnormal_trachea_morphology | 0.77358982 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.77325202 |
| 59 | MP0005334_abnormal_fat_pad | 0.76900978 |
| 60 | MP0004510_myositis | 0.74641794 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.71590935 |
| 62 | MP0001790_abnormal_immune_system | 0.71269369 |
| 63 | MP0005387_immune_system_phenotype | 0.71269369 |
| 64 | MP0008872_abnormal_physiological_respon | 0.69536033 |
| 65 | MP0005464_abnormal_platelet_physiology | 0.69070334 |
| 66 | MP0001845_abnormal_inflammatory_respons | 0.68757335 |
| 67 | MP0009115_abnormal_fat_cell | 0.68212095 |
| 68 | MP0002168_other_aberrant_phenotype | 0.67516041 |
| 69 | MP0003122_maternal_imprinting | 0.65392095 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 0.65313445 |
| 71 | MP0005000_abnormal_immune_tolerance | 0.64575098 |
| 72 | MP0002928_abnormal_bile_duct | 0.64003643 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.63710266 |
| 74 | MP0009053_abnormal_anal_canal | 0.62177761 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.59948883 |
| 76 | MP0000371_diluted_coat_color | 0.59180803 |
| 77 | MP0005448_abnormal_energy_balance | 0.58091412 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.56718048 |
| 79 | MP0003075_altered_response_to | 0.56036261 |
| 80 | MP0002723_abnormal_immune_serum | 0.55915402 |
| 81 | MP0003329_amyloid_beta_deposits | 0.54138228 |
| 82 | MP0005166_decreased_susceptibility_to | 0.53880495 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.52274533 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.52264885 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.50210553 |
| 86 | MP0005266_abnormal_metabolism | 0.50065430 |
| 87 | MP0000249_abnormal_blood_vessel | 0.48082109 |
| 88 | MP0003011_delayed_dark_adaptation | 0.48072169 |
| 89 | MP0005646_abnormal_pituitary_gland | 0.47948038 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.47794118 |
| 91 | MP0000685_abnormal_immune_system | 0.47698388 |
| 92 | MP0002822_catalepsy | 0.47547010 |
| 93 | MP0004883_abnormal_blood_vessel | 0.46643482 |
| 94 | MP0006082_CNS_inflammation | 0.45958809 |
| 95 | MP0005164_abnormal_response_to | 0.44269028 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.43287541 |
| 97 | MP0001915_intracranial_hemorrhage | 0.39114862 |
| 98 | MP0000566_synostosis | 0.38582199 |
| 99 | MP0002452_abnormal_antigen_presenting | 0.38566370 |
| 100 | MP0002970_abnormal_white_adipose | 0.38497032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.39511957 |
| 2 | Deep venous thrombosis (HP:0002625) | 8.80592480 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.71141792 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.06685594 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 7.96827917 |
| 6 | Abnormality of complement system (HP:0005339) | 7.52904185 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 6.63051939 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.53429805 |
| 9 | Joint hemorrhage (HP:0005261) | 6.35298528 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 6.04219206 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 5.82288560 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.61771283 |
| 13 | Glomerulonephritis (HP:0000099) | 5.01184813 |
| 14 | Xanthomatosis (HP:0000991) | 4.68005774 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.46730949 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.03423166 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.89583752 |
| 18 | Spontaneous abortion (HP:0005268) | 3.71164703 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.68112347 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.62315996 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.58471311 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40287810 |
| 23 | Gingival bleeding (HP:0000225) | 3.38862113 |
| 24 | Nephritis (HP:0000123) | 3.37413429 |
| 25 | Pulmonary embolism (HP:0002204) | 3.17968269 |
| 26 | Thrombophlebitis (HP:0004418) | 3.05214728 |
| 27 | Purpura (HP:0000979) | 3.00849802 |
| 28 | Hemorrhage of the eye (HP:0011885) | 3.00202867 |
| 29 | Delayed CNS myelination (HP:0002188) | 2.82813152 |
| 30 | Hyperglycinemia (HP:0002154) | 2.74147206 |
| 31 | Epidermoid cyst (HP:0200040) | 2.67745135 |
| 32 | Fair hair (HP:0002286) | 2.66054700 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 2.64580190 |
| 34 | Neonatal hypoglycemia (HP:0001998) | 2.63390455 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.59285763 |
| 36 | Hypercholesterolemia (HP:0003124) | 2.51357283 |
| 37 | Myocardial infarction (HP:0001658) | 2.48124641 |
| 38 | Hyperammonemia (HP:0001987) | 2.40560758 |
| 39 | Cholecystitis (HP:0001082) | 2.28695421 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.28695421 |
| 41 | Elevated alkaline phosphatase (HP:0003155) | 2.26933380 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 2.26399102 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.26399102 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25093530 |
| 45 | Menorrhagia (HP:0000132) | 2.23144008 |
| 46 | Gangrene (HP:0100758) | 2.21361054 |
| 47 | Increased serum ferritin (HP:0003281) | 2.21359487 |
| 48 | Anorexia (HP:0002039) | 2.17894149 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.16548416 |
| 50 | Myositis (HP:0100614) | 2.15860645 |
| 51 | Mitral stenosis (HP:0001718) | 2.15670740 |
| 52 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.15344387 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.15206267 |
| 54 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.14161149 |
| 55 | Epistaxis (HP:0000421) | 2.13587341 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13090590 |
| 57 | Orchitis (HP:0100796) | 2.10956779 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.09460710 |
| 59 | Joint swelling (HP:0001386) | 2.07769420 |
| 60 | Abnormality of iron homeostasis (HP:0011031) | 2.07623960 |
| 61 | Optic neuritis (HP:0100653) | 2.04110329 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.04110329 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.03038380 |
| 64 | Rickets (HP:0002748) | 2.02032591 |
| 65 | Ketosis (HP:0001946) | 1.95515517 |
| 66 | Osteomalacia (HP:0002749) | 1.95343057 |
| 67 | Generalized aminoaciduria (HP:0002909) | 1.94500197 |
| 68 | Hypochromic anemia (HP:0001931) | 1.90307208 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87009372 |
| 70 | Abnormality of alanine metabolism (HP:0010916) | 1.87009372 |
| 71 | Hyperalaninemia (HP:0003348) | 1.87009372 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 1.85336016 |
| 73 | Cholelithiasis (HP:0001081) | 1.83848881 |
| 74 | Metabolic acidosis (HP:0001942) | 1.79525799 |
| 75 | Hypophosphatemia (HP:0002148) | 1.79385880 |
| 76 | Recurrent abscess formation (HP:0002722) | 1.77552600 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76300860 |
| 78 | Generalized hypopigmentation of hair (HP:0011358) | 1.75216208 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74947933 |
| 80 | Fat malabsorption (HP:0002630) | 1.74622737 |
| 81 | Amyloidosis (HP:0011034) | 1.73559341 |
| 82 | Pathologic fracture (HP:0002756) | 1.72639980 |
| 83 | Lymphangioma (HP:0100764) | 1.70085807 |
| 84 | Esophageal varix (HP:0002040) | 1.69946935 |
| 85 | Vascular calcification (HP:0004934) | 1.66841373 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 1.66582238 |
| 87 | Hypophosphatemic rickets (HP:0004912) | 1.64530128 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63488592 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63488592 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63488592 |
| 91 | Reticulocytosis (HP:0001923) | 1.63479212 |
| 92 | Hypertriglyceridemia (HP:0002155) | 1.61521121 |
| 93 | Irritability (HP:0000737) | 1.61063411 |
| 94 | Abnormal tarsal ossification (HP:0008369) | 1.59819743 |
| 95 | Meningitis (HP:0001287) | 1.59657986 |
| 96 | Blue irides (HP:0000635) | 1.58661851 |
| 97 | Arthropathy (HP:0003040) | 1.55760681 |
| 98 | Pancreatitis (HP:0001733) | 1.55486550 |
| 99 | Retinal atrophy (HP:0001105) | 1.54883483 |
| 100 | Arterial thrombosis (HP:0004420) | 1.50548364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.20409452 |
| 2 | SIK1 | 3.00059129 |
| 3 | MAP4K1 | 2.94854203 |
| 4 | TRIB3 | 2.76038032 |
| 5 | BLK | 2.56087597 |
| 6 | MAP2K3 | 2.49532718 |
| 7 | TNK2 | 2.47270500 |
| 8 | FGFR4 | 2.34838444 |
| 9 | MAP3K3 | 2.24253848 |
| 10 | PRPF4B | 2.14719277 |
| 11 | SIK2 | 1.90397372 |
| 12 | RIPK4 | 1.84961850 |
| 13 | TYK2 | 1.83456754 |
| 14 | IRAK4 | 1.68599906 |
| 15 | NTRK3 | 1.66662887 |
| 16 | EPHA3 | 1.66132018 |
| 17 | SIK3 | 1.61766241 |
| 18 | RIPK1 | 1.54041841 |
| 19 | MARK2 | 1.53172906 |
| 20 | MAP3K11 | 1.48684766 |
| 21 | EPHB1 | 1.48426622 |
| 22 | DYRK1B | 1.33006113 |
| 23 | TAOK1 | 1.32675084 |
| 24 | WNK4 | 1.31165723 |
| 25 | DAPK2 | 1.30922884 |
| 26 | CAMKK1 | 1.29322034 |
| 27 | JAK3 | 1.25309937 |
| 28 | MAP3K7 | 1.21438397 |
| 29 | MAP2K6 | 1.13077201 |
| 30 | TBK1 | 1.13013045 |
| 31 | IKBKE | 1.12645056 |
| 32 | PRKD3 | 1.09844784 |
| 33 | CDK9 | 1.09222503 |
| 34 | MAPK7 | 1.05894550 |
| 35 | MAP2K4 | 1.05591580 |
| 36 | FGR | 1.04128282 |
| 37 | CSK | 1.02432637 |
| 38 | HIPK2 | 1.00837663 |
| 39 | NTRK2 | 1.00390936 |
| 40 | PKN2 | 1.00268412 |
| 41 | CDC42BPA | 0.99093059 |
| 42 | MAP3K1 | 0.98821536 |
| 43 | ITK | 0.93393019 |
| 44 | ZAP70 | 0.90489496 |
| 45 | PRKAA2 | 0.90346100 |
| 46 | SYK | 0.89716967 |
| 47 | FGFR3 | 0.88310156 |
| 48 | IKBKB | 0.87578675 |
| 49 | MAPK12 | 0.86782137 |
| 50 | CAMKK2 | 0.84240990 |
| 51 | SGK223 | 0.84130030 |
| 52 | SGK494 | 0.84130030 |
| 53 | PTK6 | 0.83840894 |
| 54 | MAP3K6 | 0.82767638 |
| 55 | CAMK4 | 0.81436307 |
| 56 | GRK6 | 0.81251901 |
| 57 | PIK3CA | 0.81146173 |
| 58 | MAPK11 | 0.80583149 |
| 59 | CDK12 | 0.79418560 |
| 60 | LMTK2 | 0.79282577 |
| 61 | MAP3K14 | 0.78390989 |
| 62 | WNK1 | 0.77822845 |
| 63 | MAPK15 | 0.76298190 |
| 64 | JAK2 | 0.75816853 |
| 65 | ICK | 0.75431799 |
| 66 | PRKD2 | 0.75376246 |
| 67 | PDPK1 | 0.74876355 |
| 68 | FES | 0.74378105 |
| 69 | RPS6KA2 | 0.73412506 |
| 70 | PDK1 | 0.73284879 |
| 71 | JAK1 | 0.72775893 |
| 72 | MAP3K13 | 0.71740135 |
| 73 | PRKCZ | 0.70920333 |
| 74 | LCK | 0.69111318 |
| 75 | RPS6KL1 | 0.68100744 |
| 76 | RPS6KC1 | 0.68100744 |
| 77 | FGFR2 | 0.67939833 |
| 78 | TYRO3 | 0.65835103 |
| 79 | BCKDK | 0.65568946 |
| 80 | CSF1R | 0.64375303 |
| 81 | CHUK | 0.64212047 |
| 82 | BTK | 0.64083837 |
| 83 | DDR2 | 0.63182250 |
| 84 | LYN | 0.63015375 |
| 85 | HCK | 0.62981216 |
| 86 | EEF2K | 0.62098440 |
| 87 | TAOK2 | 0.59607640 |
| 88 | PRKAA1 | 0.58834867 |
| 89 | RPS6KA6 | 0.58690536 |
| 90 | SGK2 | 0.57704671 |
| 91 | PRKACG | 0.57581587 |
| 92 | SMG1 | 0.55274983 |
| 93 | MAP4K2 | 0.50406512 |
| 94 | TXK | 0.49580098 |
| 95 | GRK7 | 0.47864191 |
| 96 | TAOK3 | 0.46893632 |
| 97 | CAMK1D | 0.46474586 |
| 98 | MARK3 | 0.46392299 |
| 99 | RET | 0.43869345 |
| 100 | PRKCG | 0.43683091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.58721946 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.58131422 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.30870172 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.45343850 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.18647745 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.12716277 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.01109915 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92887825 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.70337996 |
| 10 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.54875729 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.53907610 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.53162175 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46637277 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.26403350 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.11811676 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.11629222 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05960620 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93901341 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90652272 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.90202914 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86504652 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77218735 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.76514465 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.73225634 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62188781 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56210153 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48759468 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.39763568 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29112837 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.20996392 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19100026 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.18574827 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.17983393 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14479354 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12526324 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06815881 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05262256 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99815564 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98168041 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96975180 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94664796 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92886605 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88877175 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85896783 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84339876 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.77643298 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72857350 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67922404 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65279398 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63852893 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60041354 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58513135 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51962683 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51141529 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.48716192 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47963093 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41718761 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41310726 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41270243 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37449116 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.35517381 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35212559 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26019629 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25629850 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24437797 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23937787 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20447964 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19406557 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.18868847 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17765298 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.15075016 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.15006582 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.13609457 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13474858 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13025303 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.12323955 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11789693 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10805795 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.09620391 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.06296414 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.05388304 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.00309939 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.00010606 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | -0.0947292 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0935278 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0901799 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0859209 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | -0.0814792 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.0808911 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | -0.0683132 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0601429 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0598476 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0550999 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | -0.0500043 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | -0.0340456 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0174767 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0163205 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0104174 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0085633 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0085054 |

